PL1797115T3 - Domena wiążąca bakteryjnej syntazy ATP - Google Patents

Domena wiążąca bakteryjnej syntazy ATP

Info

Publication number
PL1797115T3
PL1797115T3 PL05794520T PL05794520T PL1797115T3 PL 1797115 T3 PL1797115 T3 PL 1797115T3 PL 05794520 T PL05794520 T PL 05794520T PL 05794520 T PL05794520 T PL 05794520T PL 1797115 T3 PL1797115 T3 PL 1797115T3
Authority
PL
Poland
Prior art keywords
binding domain
atp synthase
bacterial atp
synthase binding
bacterial
Prior art date
Application number
PL05794520T
Other languages
English (en)
Inventor
K.J.L.M Andries
Hinrich W.H. GÖHLMANN
J.-M.E.F.M. Neefs
Peter K.M VERHASSELT
Johann Winkler
Marc René DE JONGE
Lucien Maria Henricus Koymans
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of PL1797115T3 publication Critical patent/PL1797115T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
PL05794520T 2004-09-28 2005-09-28 Domena wiążąca bakteryjnej syntazy ATP PL1797115T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP04104720 2004-09-28
US62050004P 2004-10-20 2004-10-20
PCT/EP2005/054893 WO2006035051A1 (en) 2004-09-28 2005-09-28 A bacterial atp synthase binding domain
EP05794520.6A EP1797115B1 (en) 2004-09-28 2005-09-28 A bacterial atp synthase binding domain

Publications (1)

Publication Number Publication Date
PL1797115T3 true PL1797115T3 (pl) 2017-12-29

Family

ID=38965678

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05794520T PL1797115T3 (pl) 2004-09-28 2005-09-28 Domena wiążąca bakteryjnej syntazy ATP

Country Status (24)

Country Link
US (2) US8088891B2 (pl)
EP (1) EP1797115B1 (pl)
JP (2) JP2008515395A (pl)
KR (1) KR101539021B1 (pl)
CN (1) CN101065397B (pl)
AU (2) AU2005288848A1 (pl)
CA (1) CA2579971C (pl)
CY (1) CY1119568T1 (pl)
DK (1) DK1797115T3 (pl)
ES (1) ES2636980T3 (pl)
HR (1) HRP20171388T1 (pl)
HU (1) HUE033609T2 (pl)
IL (1) IL182185A (pl)
LT (1) LT1797115T (pl)
ME (1) ME02935B (pl)
NO (1) NO342699B1 (pl)
NZ (1) NZ553693A (pl)
PL (1) PL1797115T3 (pl)
PT (1) PT1797115T (pl)
RS (1) RS56357B1 (pl)
RU (1) RU2418001C2 (pl)
SI (1) SI1797115T1 (pl)
WO (1) WO2006035051A1 (pl)
ZA (1) ZA200702540B (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2440736A (en) * 2006-08-10 2008-02-13 Medical Res Council Crystals of mutant p53 polypeptidtes
JO2970B1 (en) 2006-12-06 2016-03-15 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
JO2685B1 (en) 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان في Quinoline antibacterial derivatives
JO3271B1 (ar) 2006-12-06 2018-09-16 Janssen Pharmaceutica Nv مشتقات الكوينولين المضادة للجراثيم
CN104254527B (zh) 2012-04-27 2017-05-31 詹森药业有限公司 抗菌的喹啉衍生物
ES2607879T3 (es) 2012-04-27 2017-04-04 Janssen Pharmaceutica N.V. Derivados de quinolina antibacterianos
US8454434B1 (en) * 2012-06-15 2013-06-04 Igt Gaming system and method for providing an offer and acceptance game with progressive awards associated with a quantity of progressive tokens
JP5580383B2 (ja) 2012-10-05 2014-08-27 株式会社 資生堂 美容機器及び通電方法及び記録媒体
KR101522087B1 (ko) * 2013-06-19 2015-05-28 삼성에스디에스 주식회사 미스매치를 고려한 염기 서열 정렬 시스템 및 방법
CN110373399B (zh) * 2019-07-09 2021-05-28 湖南省植物保护研究所 一种沼泽红假单胞菌Atps2蛋白及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE146783T1 (de) 1991-11-01 1997-01-15 Upjohn Co Substituierte aryl- und heteroaryl- phenyloxazolidinone
US6583266B1 (en) * 1993-08-19 2003-06-24 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to mycobacterium tuberculosis and leprae for diagnostics and therapeutics
RU2245719C2 (ru) * 2000-03-28 2005-02-10 Каунсил Оф Сайентифик Энд Индастриал Рисерч Тимолсодержащая композиция, полезная для лечения устойчивых к лекарственным средствам бактериальных инфекций
WO2001089531A1 (en) * 2000-05-19 2001-11-29 Genetics Institute, Llc Crystal structures of p- selectin,ep0105895-selectin complexes, and uses thereof
JP4122216B2 (ja) * 2000-09-19 2008-07-23 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド ＧＳＫ−３βタンパク質の特徴づけおよびその使用方法
AU2002306849A1 (en) * 2001-03-21 2002-10-08 Elitra Pharmaceuticals, Inc. Identification of essential genes in microorganisms
PT1443937E (pt) 2001-11-13 2008-09-23 Ortho Mcneil Janssen Pharm 1,4-benzodiazepinas substituídas e as suas utilizações para o tratamento de cancro
ATE463482T1 (de) * 2002-07-25 2010-04-15 Janssen Pharmaceutica Nv Chinolinderivate und deren verwendung als mycobakterielle inhibitoren
AU2002951853A0 (en) * 2002-10-04 2002-10-24 Commonwealth Scientific And Industrial Research Organisation Crystal structure of erbb2 and uses thereof

Also Published As

Publication number Publication date
JP5837852B2 (ja) 2015-12-24
ME02935B (me) 2018-04-20
KR20070073823A (ko) 2007-07-10
CY1119568T1 (el) 2018-03-07
NO342699B1 (no) 2018-07-09
AU2012216368B2 (en) 2017-04-13
NZ553693A (en) 2012-05-25
CA2579971C (en) 2018-02-13
CN101065397B (zh) 2015-10-21
KR101539021B1 (ko) 2015-07-23
JP2012210210A (ja) 2012-11-01
IL182185A (en) 2017-12-31
CN101065397A (zh) 2007-10-31
ZA200702540B (en) 2008-08-27
EP1797115B1 (en) 2017-06-21
CA2579971A1 (en) 2006-04-06
RS56357B1 (sr) 2017-12-29
HK1114619A1 (zh) 2008-11-07
RU2007116144A (ru) 2008-11-10
HRP20171388T1 (hr) 2017-11-03
US8378085B2 (en) 2013-02-19
EP1797115A1 (en) 2007-06-20
US20090298874A1 (en) 2009-12-03
PT1797115T (pt) 2017-08-29
JP2008515395A (ja) 2008-05-15
US20120219964A1 (en) 2012-08-30
HUE033609T2 (en) 2017-12-28
US8088891B2 (en) 2012-01-03
AU2012216368A1 (en) 2012-09-13
AU2005288848A1 (en) 2006-04-06
NO20072237L (no) 2007-06-25
ES2636980T3 (es) 2017-10-10
RU2418001C2 (ru) 2011-05-10
LT1797115T (lt) 2017-10-10
DK1797115T3 (en) 2017-10-02
SI1797115T1 (sl) 2017-10-30
WO2006035051A1 (en) 2006-04-06
IL182185A0 (en) 2007-07-24

Similar Documents

Publication Publication Date Title
ZA200702540B (en) A bacterial ATP synthase binding domain
PL1866551T3 (pl) Wkładka łącząca
EP1883627A4 (en) BIRTH DOMAIN BINDER COMPOUNDS
ZA200809733B (en) Iap bi domain binding compounds
EP1908602A4 (en) BINDING DEVICE
GB0600146D0 (en) A balanced amplifier
GB2453894B (en) Binding assembly
GB0520523D0 (en) Object binding
GB0410627D0 (en) Specific binding members
GB2456869B (en) Adaptive Information
GB2432538B (en) Ball-game training aid
GB0400649D0 (en) Insert
GB0519670D0 (en) Receptacles
GB2433914B (en) Book binding
ZA200610625B (en) A putting aid
GB0618070D0 (en) Low cost flipbook
AU3229P (en) Lusa Trifolium resupinatum
GB0511152D0 (en) Music aid
GB0525885D0 (en) Object binding
GB0520934D0 (en) Object binding
GB0623233D0 (en) Leaf prodder
PL115567U1 (en) A mug
AU2005903129A0 (en) Cover for a soft furnishing item
GB0519212D0 (en) A training aid
AU2006903332A0 (en) Cover For a Soft Furnishing Item